Chinese TAVR player buys German third-gen peer, aims for global market after $37M from Goldman Sachs
Venus Medtech aims to have the first transcatheter aortic valve implantation system cleared by the China Food and Drug Administration (CFDA). It also has a transcatheter pulmonic valve that is finishing clinical trials, which would also be a first for the CFDA.
IBM will announce a pair of new Watson Health initiatives. One is with the American Cancer Society to apply the power of artificial intelligence to patient-oriented healthcare information, the other is an effort dubbed IBM Health Corps that aims to apply Watson's AI capabilities to better solve global health challenges.
UPDATED: VCs build biggest Brazilian med tech via two acquisitions, infuse with $21M and add ex-GE exec
Adavium Medical has made a lot of moves fast to thrust itself into the position of the largest medical equipment and diagnostics company in Brazil. It just acquired two of the largest Brazilian clinical diagnostics companies, raised a $21 million Series C round to finance these and other anticipated deals, hired an ex-GE Healthcare exec as COO and president of diagnostics and changed its name from Advance Medical.
Turkey may be Europe's sixth largest pharmaceutical industry, but it's looking to ascend the ranks with a boost from GE Healthcare. The company is launching a collaborative research scheme to support Turkey's bioprocessing development and manufacturing.
BioPharmaSpec is expanding its business into the potentially lucrative Asian market as new business development teams begin work in India and the Asia-Pacific region this month.
GE Healthcare launched its hand-held ultrasound, Vscan Access, last May at a World Health Organization meeting in Switzerland. Now, the technology is in the process of becoming more widely available and incorporated into routine pregnancy care.
Expansion-minded CRO PSI has opened up shop in Israel, expanding its global reach to cover a market the company believes is poised for growth.
R&G Pharma Studies, a Chinese CRO, is deepening its relationship with clinical trial tech provider Medidata, adopting the company's cloud-based management system.
By year-end, the United Arab Emirates (UAE) can expect to have a new manufacturing plant producing drugs for the country as a Saudi drugmaker completes the first phase of a project there.
Chinese CRO WuXi PharmaTech just went private in a $3.3 billion deal, but the company is looking to get back on the public markets through an IPO for its biologics business, according to Bloomberg.